We are live on ! Find out more
Calamos Advisors

Calamos Advisors Portfolio holdings

AUM $28.2B
1-Year Est. Return 21.78%
This Fund
S&P 500
This Quarter Est. Return
+0.71%
1 Year Est. Return
+21.78%
3 Year Est. Return
+69.57%
5 Year Est. Return
+92%
10 Year Est. Return
+282.63%
AUM
$22.9B
AUM Growth
+$1.01B
Cap. Flow
-$5.41B
Cap. Flow %
-23.63%
Top 10 Hldgs %
20.65%
Holding
1,090
New
128
Increased
343
Reduced
93
Closed
104

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$41.8M
2
AAPL icon
Apple
AAPL
+$35.4M
3
AMZN icon
Amazon
AMZN
+$34.6M
4
AESC
The AES Corporation
AESC
+$30.3M
5
ADBE icon
Adobe
ADBE
+$25.6M

Sector Composition

Rank Sector Weight
1 Technology 15.1%
2 Financials 8.11%
3 Healthcare 7.32%
4 Consumer Discretionary 6.91%
5 Communication Services 6.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ASAN icon
326
Asana
ASAN
$1.89B
$8.5M 0.04%
81,811
-13,328
-14% -$1.11M
DRAYU
327
DELISTED
Macondray Capital Acquisition Corp. I Unit
DRAYU
$8.49M 0.04%
+850,450
New +$8.44M
META icon
328
PUT
Meta Platforms (Facebook)
META
$1.51T
$8.48M 0.04%
+25,000
New +$9M
CTVA icon
329
Corteva
CTVA
$59.5B
$8.32M 0.04%
197,787
+17,452
+10% +$755K
CNQ icon
330
Canadian Natural Resources
CNQ
$92.2B
$8.31M 0.04%
+464,236
New +$7.64M
NOK icon
331
Nokia
NOK
$49.9B
$8.28M 0.04%
1,520,000
CTXS
332
DELISTED
Citrix Systems Inc
CTXS
$8.22M 0.04%
76,561
+6,756
+10% +$729K
EL icon
333
Estee Lauder
EL
$30.7B
$8.17M 0.04%
27,253
-159
-0.6% -$51.9K
VLO icon
334
Valero Energy
VLO
$88.7B
$8.12M 0.04%
115,122
+7,010
+6% +$467K
ZBH icon
335
Zimmer Biomet
ZBH
$18.5B
$8.11M 0.04%
57,057
+5,035
+10% +$741K
NUE icon
336
Nucor
NUE
$60.5B
$8.11M 0.04%
82,290
+290
+0.4% +$30.8K
DCRDU
337
DELISTED
Decarbonization Plus Acquisition Corporation IV Unit
DCRDU
$8.1M 0.04%
+800,000
New +$8.05M
ALLE icon
338
Allegion
ALLE
$13.7B
$8.09M 0.04%
61,210
+5,401
+10% +$751K
HPQ icon
339
HP
HPQ
$25.9B
$8.08M 0.04%
295,385
+26,065
+10% +$749K
WQGA.U
340
DELISTED
World Quantum Growth Acquisition Corp. Units, each consisting of one Class A ordinary share and one-half of one redeemable warrant to acquire one Class A ordinary share
WQGA.U
$8.04M 0.04%
+800,000
New +$8M
RDS.A
341
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
$7.89M 0.03%
+177,000
New +$7.14M
WAVC.U
342
DELISTED
Waverley Capital Acquisition Corp. 1 Units, each consisting of one Class A Ordinary Share and one-third of one redeemable warrant
WAVC.U
$7.89M 0.03%
+800,000
New +$7.93M
ZLSWU
343
DELISTED
Zalatoris II Acquisition Corp Unit
ZLSWU
$7.86M 0.03%
+800,000
New +$7.89M
FICVU
344
DELISTED
Frontier Investment Corp Units
FICVU
$7.86M 0.03%
+800,000
New +$7.93M
LOCC.U
345
DELISTED
Live Oak Crestview Climate Acquisition Corp. Units, each consisting of one share of Class A common stock, and one-third of one warrant
LOCC.U
$7.85M 0.03%
+800,000
New +$7.87M
AFL icon
346
Aflac
AFL
$65.9B
$7.75M 0.03%
148,772
+13,128
+10% +$718K
NTAP icon
347
NetApp
NTAP
$34.2B
$7.56M 0.03%
84,273
+7,436
+10% +$628K
FE icon
348
FirstEnergy
FE
$28.7B
$7.55M 0.03%
211,937
+18,701
+10% +$710K
IVV icon
349
iShares Core S&P 500 ETF
IVV
$871B
$7.53M 0.03%
17,478
-19
-0.1% -$8.42K
OSI.U
350
DELISTED
Osiris Acquisition Corp. Units, each consisting of one share of Class A common stock, and one-half of one redeemable warrant
OSI.U
$7.46M 0.03%
750,000

Similar funds

Calamos Advisors's Q3 2021 Portfolio in Review

As of Q3 2021, Calamos Advisors held 1,090 positions worth $22.9B, up 4.6% from $21.9B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Calamos Advisors withdrew a net $5.41B in Q3 2021, closing 104 positions and reducing 93 holdings. Its most notable exit was Alexion Pharmaceuticals, an estimated $31.2M position sold in full.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Calamos Advisors opened a new position in AstraZeneca worth $17.8M.

  • Calamos Advisors's largest Q3 2021 buy was AstraZeneca: 148,454 shares worth $17.8M.
  • Calamos Advisors added most to Microsoft in Q3 2021, an estimated $41.8M increase.
  • Calamos Advisors's biggest Q3 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $236M.
  • Calamos Advisors fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $31.2M.
  • Calamos Advisors's ten largest holdings make up 21% of its $22.9B portfolio in Q3 2021.
  • Calamos Advisors opened 128 new positions and closed 104 in Q3 2021.
  • Calamos Advisors's portfolio value rose 4.6% quarter-over-quarter to $22.9B.

Based on Calamos Advisors's 13F filing for Q3 2021, filed 26 Oct 2021.